Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angie B Dull

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cell Death Discovery|June 5, 2021
Smac-mimetic enhances antitumor effect of standard chemotherapy in ovarian cancer models via Caspase 8-independent mechanismLidia F Hernandez, Angie B Dull, Soumya Korrapati, et al.
Archives of Biochemistry and Biophysics|October 4, 2002
Characterization of the phosphorylation status of the hepatitis B virus X-associated protein 2Angie B Dull, David B Carlson, John R Petrulis, et al.
Methods in Enzymology|November 18, 2006
High-content fluorescence-based screening for epigenetic modulatorsElisabeth D Martinez, Angie B Dull, John A Beutler, et al.
Journal of Biomedicine & Biotechnology|January 15, 2011
Identification of four potential epigenetic modulators from the NCI structural diversity library using a cell-based assayAnne M Best, Jianjun Chang, Angie B Dull, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 16, 2005
An estrogen receptor chimera senses ligands by nuclear translocationElisabeth D Martinez, Geetha V Rayasam, Angie B Dull, et al.
Journal of Biomolecular Screening|September 21, 2013
Identification of compounds by high-content screening that induce cytoplasmic to nuclear localization of a fluorescent estrogen receptor α chimera and exhibit agonist or antagonist activity in vitroAngie B Dull, Anuja A George, Ekaterina I Goncharova, et al.
Oncotarget|April 24, 2018
Development of a quantitative pharmacodynamic assay for apoptosis in fixed tumor tissue and its application in distinguishing cytotoxic drug-induced DNA double strand breaks from DNA double strand breaks associated with apoptosisAngie B Dull, Deborah Wilsker, Melinda Hollingshead, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 23, 2019
Evaluation of Pharmacodynamic Responses to Cancer Therapeutic Agents Using DNA Damage MarkersDeborah F Wilsker, Allison M Barrett, Angie B Dull, et al.
Oncotarget|October 22, 2021
ATR inhibition reverses the resistance of homologous recombination deficient MGMT<sup>low</sup>/MMR<sup>proficient</sup> cancer cells to temozolomideLara H El Touny, Curtis Hose, John Connelly, et al.
Oncotarget|November 20, 2020
Phase I trial of TRC102 (methoxyamine HCl) in combination with temozolomide in patients with relapsed solid tumors and lymphomasGeraldine O'Sullivan Coyne, Shivaani Kummar, Robert S Meehan, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cell Death Discovery|June 5, 2021
Smac-mimetic enhances antitumor effect of standard chemotherapy in ovarian cancer models via Caspase 8-independent mechanismLidia F Hernandez, Angie B Dull, Soumya Korrapati, et al.
Archives of Biochemistry and Biophysics|October 4, 2002
Characterization of the phosphorylation status of the hepatitis B virus X-associated protein 2Angie B Dull, David B Carlson, John R Petrulis, et al.
Methods in Enzymology|November 18, 2006
High-content fluorescence-based screening for epigenetic modulatorsElisabeth D Martinez, Angie B Dull, John A Beutler, et al.
Journal of Biomedicine & Biotechnology|January 15, 2011
Identification of four potential epigenetic modulators from the NCI structural diversity library using a cell-based assayAnne M Best, Jianjun Chang, Angie B Dull, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 16, 2005
An estrogen receptor chimera senses ligands by nuclear translocationElisabeth D Martinez, Geetha V Rayasam, Angie B Dull, et al.
Journal of Biomolecular Screening|September 21, 2013
Identification of compounds by high-content screening that induce cytoplasmic to nuclear localization of a fluorescent estrogen receptor α chimera and exhibit agonist or antagonist activity in vitroAngie B Dull, Anuja A George, Ekaterina I Goncharova, et al.
Oncotarget|April 24, 2018
Development of a quantitative pharmacodynamic assay for apoptosis in fixed tumor tissue and its application in distinguishing cytotoxic drug-induced DNA double strand breaks from DNA double strand breaks associated with apoptosisAngie B Dull, Deborah Wilsker, Melinda Hollingshead, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 23, 2019
Evaluation of Pharmacodynamic Responses to Cancer Therapeutic Agents Using DNA Damage MarkersDeborah F Wilsker, Allison M Barrett, Angie B Dull, et al.
Oncotarget|October 22, 2021
ATR inhibition reverses the resistance of homologous recombination deficient MGMT<sup>low</sup>/MMR<sup>proficient</sup> cancer cells to temozolomideLara H El Touny, Curtis Hose, John Connelly, et al.
Oncotarget|November 20, 2020
Phase I trial of TRC102 (methoxyamine HCl) in combination with temozolomide in patients with relapsed solid tumors and lymphomasGeraldine O'Sullivan Coyne, Shivaani Kummar, Robert S Meehan, et al.
Pageof 1